Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023

Glutamate neurotoxicity and diseases of the nervous system

Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188

Biological insights from 108 schizophrenia-associated genetic loci

Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577

From inflammation to sickness and depression: when the immune system subjugates the brain

Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433

Immunobiology: the immune system in health and disease

(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,111

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848

Immune-Endocrine Links to Gregariousness in Wild House Mice

Lopes, P. C., Carlitz, E. H. D., Kindel, M., & König, B. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00010 · Cited by 9

Serum tumor necrosis factor-like weak inducer of apoptosis levels are elevated in schizophrenia

Kılıç, F., Işık, Ü., Usta, A., & Demirdaş, A. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-0950 · Cited by 9

Age Effect on Incidence, Physical, and Psychiatric Comorbidity for Sudden Cardiac Death in Schizophrenia: Effet de l’âge sur l’incidence, la comorbidité physique et psychiatrique de la mort cardiaque subite dans la schizophrénie

Chen, P., Tsai, S., Pan, C., Chang, H., Chen, Y., Su, S., Chen, C., & Kuo, C. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720948429 · Cited by 9

Using iPSC Models to Understand the Role of Estrogen in Neuron–Glia Interactions in Schizophrenia and Bipolar Disorder

de Assis, D. R., Szabó, A., Osete, J. R., Puppo, F., O’Connell, K. S., Akkouh, I. A., Hughes, T., Frei, E., Andreassen, O. A., & Djurovic, S. (2021) · Cells · doi:10.3390/cells10020209 · Cited by 10

Anxiolytic-like effects of hochuekkito in lipopolysaccharide-treated mice involve interleukin-6 inhibition

Ushio, S., Wada, Y., Nakamura, M., Matsumoto, D., Hoshika, K., Shiromizu, S., Iwata, N., Esumi, S., Kajizono, M., Kitamura, Y., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.890048 · Cited by 11

Increased markers of inflammation after cannabis cessation and their association with psychotic symptoms

Roméo, B., Lestra, V., Martelli, C., Amirouche, A., Benyamina, A., & Hamdani, N. (2023) · Acta Neuropsychiatrica · doi:10.1017/neu.2023.24 · Cited by 9

Toxoplasma gondii infection by serological and molecular methods in schizophrenia patients with and without suicide attempts: An age‐sex‐matched case‐control study

Akgül, Ö., Demirel, Ö. F., Poyraz, C. A., Aydın, E. T., Cesur, N. U., Bulu, E., Sapmaz, B., Çalışkan, R., & Öner, Y. A. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14449 · Cited by 9

Schizotypy, Lifestyle Behaviors, and Health Indicators in a Young Adult Sample

Dinzeo, T. J., & Thayasivam, U. (2021) · Behavioral Sciences · doi:10.3390/bs11120179 · Cited by 9

Anti‐TSNARE1 IgG plasma levels differ by sex in patients with schizophrenia in a Chinese population

Li, C., Whelan, R., Yang, H., Jiang, Y., Qiu, C., Meng, Q., & Wei, J. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12704 · Cited by 10

Anti-NMDAR Antibodies as a New Piece in Schizophrenia’s Puzzle

Teixeira, A. L., Rocha, N. P., & Zhang, X. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0009 · Cited by 9

Role of short-chain fatty acids in the gut-brain axis in schizophrenia: contribution to immune activation and pathophysiology in humans and micePreprint

Zhu, F., Wang, W., Ma, Q., Yang, Z., Fan, Y., Ju, Y., Guo, R., Wang, Q., Mu, X., Zhao, B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.11.021915 · Cited by 9

The Emerging Role of Toll-Like Receptor-Mediated Neuroinflammatory Signals in Psychiatric Disorders and Acquired Epilepsy

Chaudhary, A., Mehra, P., Keshri, A. K., Rawat, S. S., Mishra, A., & Prasad, A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03639-7 · Cited by 8

Increased NLRP1 mRNA and Protein Expression Suggests Inflammasome Activation in the Dorsolateral Prefrontal and Medial Orbitofrontal Cortex in Schizophrenia

Španić, E., Vogrinc, D., Fuller, H. R., Horvat, L. L., Mayer, D., Kopić, J., Pintarić, K., Leko, M. B., Pravica, M., Krsnik, Ž., et al. (2024) · Biomolecules · doi:10.3390/biom14030302 · Cited by 8

Chronological transitions of hepatocyte growth factor treatment effects in spinal cord injury tissue

Okano, Y., Kase, Y., Suematsu, Y., Nakamura, M., & Okano, H. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00322-9 · Cited by 8

Causality between autoimmune diseases and schizophrenia: a bidirectional Mendelian randomization study

Duan, L., Li, S., Chen, D., Shi, Y., Zhou, X., & Feng, Y. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06287-w · Cited by 9

Targeting the gut microbiota-inflammation-brain axis as a potential therapeutic strategy for psychiatric disorders: A Mendelian randomization analysis

Wu, W., Li, S., & Ye, Z. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.01.050 · Cited by 9

Unravelling the Viral Hypothesis of Schizophrenia: A Comprehensive Review of Mechanisms and Evidence

Sighencea, M. G., & Trifu, S. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157429 · Cited by 9

Quercetin exerts neuroprotective effects through activation of PI3K/AKT/CREB/BDNF signaling pathway in double blow model-induced schizophrenia-like mice

Yang, Y., Li, M., Liu, Y., Luo, B., Ge, M., Zhang, K., liu, H., & He, H. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178272 · Cited by 8

Role of Oxidative Stress in Pathophysiological Progression of Schizophrenia

Bhatt, S., Upadhyay, T., Patil, C., Pai, K. S. R., Chellappan, D. K., & Dua, K. (2022) · Current Psychiatry Research and Reviews · doi:10.2174/2666082218666220822154558 · Cited by 8

Clozapine Suppresses the Gene Expression and the Production of Cytokines and Up-Regulates Cyclooxygenase 2 mRNA in Human Astroglial Cells

Yuhas, Y., Ashkenazi, S., Berent, E., & Weizman, A. (2022) · Brain Sciences · doi:10.3390/brainsci12121703 · Cited by 9

Negative symptoms and neurocognition in drug-naïve schizophrenia: moderating role of plasma neutrophil gelatinase-associated lipocalin (NGAL) and interferon-gamma (INF-γ)

Li, M., Luo, G., Qiu, Y., Zhang, X., Sun, X., Li, Y., Zhao, Y., Sun, W., Yang, S., & Li, J. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01650-6 · Cited by 8

Glycocalyx shedding patterns identifies antipsychotic-naïve patients with first-episode psychosis

Andersen, H. G., DellaValle, B., Bøgehave, H., Mogensen, P. B., Hahn, M., Goth, C. K., Sørensen, M. E., Sigvard, A. K., Tangmose, K., Bojesen, K. B., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116037 · Cited by 8

Women and schizophrenia: planning for the future

Brzezinski‐Sinai, N. A., & Seeman, M. V. (2017) · Future Neurology · doi:10.2217/fnl-2016-0031 · Cited by 8

Immunological Processes in Schizophrenia Pathology: Potential Biomarkers?

Notter, T. (2018) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_43 · Cited by 9

The Effect of Guilingji Capsules on Vascular Mild Cognitive Impairment: A Randomized, Double-Blind, Controlled Trial

Zhang, H., Chen, H., Pei, H., Wang, H., Ma, L., & Li, H. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4778163 · Cited by 9

The molecular pathology of neurodegenerative and psychiatric disorders

Yan, P., Deng, Y. M., Su, X., Kong, H., Zhang, Y., Li, W., & Kong, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00007-5 · Cited by 8

The Role of Th17 Cells in Immunopathogenesis of Neuroinflammatory Disorders

Pourgholaminejad, A., & Tahmasebinia, F. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_3 · Cited by 8

Serum galectin-3 levels are decreased in schizophrenia

Kılıç, F., Işık, Ü., Demirdaş, A., & Usta, A. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0699 · Cited by 8

Gut Microbiota Markers for Antipsychotics Induced Metabolic Disturbance in Drug Naïve Patients with First Episode Schizophrenia – A 24 Weeks Follow-up StudyPreprint

Li, X., Yuan, X., Pang, L., Yu, M., Wang, S., Zhang, X., Hu, S., Wang, Y., Andreassen, O. A., & Song, X. (2021) · medRxiv · doi:10.1101/2020.12.26.20248886 · Cited by 8

Identifying periphery biomarkers of first-episode drug-naïve patients with schizophrenia using machine-learning-based strategies

Pan, B., Li, X., Weng, J., Xu, X., Yu, P., Zhao, Y., Yu, D., Zhang, X., & Tang, X. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111302 · Cited by 8

The role of neuroinflammation in schizophrenia: Focus on Th17 cells functions

Melnikov, M., Lopatina, A., Sviridova, A., Chugunov, A. V., Vavilis, T., Stamatellos, V., Stamoula, Ε., & Cosentino, M. (2025) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2025.104629 · Cited by 7

Microglia and microbiome in schizophrenia: can immunomodulation improve symptoms?

Juckel, G., & Freund, N. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02605-w · Cited by 7

Genome-wide DNA methylation analysis in families with multiple individuals diagnosed with schizophrenia and intellectual disability

Zhang, S., Shi, K., Lyu, N., Zhang, Y., Liang, G., Zhang, W., Wang, X., Wen, H., Wen, L., Ma, H., et al. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2023.2198595 · Cited by 7

Dual administration of lipopolysaccharide induces behavioural changes in rats relevant to psychotic disorders

Zheng, Y., Tufvesson‐Alm, M., Trepci, A., Imbeault, S., Li, X., Schwieler, L., Engberg, G., & Erhardt, S. (2023) · Acta Neuropsychiatrica · doi:10.1017/neu.2023.40 · Cited by 8

Temporal changes of gene expression in health, schizophrenia, bipolar disorder, and major depressive disorder

Arakelyan, A., Avagyan, S., Kurnosov, A., Mkrtchyan, T., Mkrtchyan, G., Zakharyan, R., Mayilyan, K. R., & Binder, H. (2024) · Schizophrenia · doi:10.1038/s41537-024-00443-7 · Cited by 6

Compensatory thickening of cortical thickness in early stage of schizophrenia

Wang, Y., Fan, L., He, Y., Yuan, L., Li, Z., Zheng, W., Tang, J., Li, C., Jin, K., Liu, W., et al. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae255 · Cited by 7

Systematic review of Mendelian randomization studies on antihypertensive drugs

Fan, B., Zhang, J., & Zhao, J. V. (2024) · BMC Medicine · doi:10.1186/s12916-024-03760-x · Cited by 9

Lights and shadows of clozapine on the immune system in schizophrenia: a narrative literature review

Li, J., Zhao, W., & Wang, Y. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01558-1 · Cited by 7

Oxidative Stress Impact on the Transcriptome of Differentiating Neuroblastoma Cells: Implication for Psychiatric Disorders

Khavari, B., Mahmoudi, E., Geaghan, M. P., & Cairns, M. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239182 · Cited by 8

Brain anomalies in early psychosis: From secondary to primary psychosis

Iftimovici, A., Chaumette, B., Duchesnay, É., & Krebs, M. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104716 · Cited by 7

History and main research of psychoneuroimmunology in China

Wang, W., Lin, W., Chen, G., & You, Z. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100562 · Cited by 8

Association of TLR-4 896A/G, TLR-4 1196C/T, and TLR-9 C/T polymorphism with schizophrenia in Indian Bengalee patient

Gurung, J., Bera, N. K., Lama, M., & Singh, B. (2022) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_263_22 · Cited by 7

An examination of plasma autoantibodies against voltage gated calcium channels in schizophrenia

McLean, R. T., Buist, E., Clair, D. S., & Wei, J. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100603 · Cited by 7

Cytokines in psychosis: from mechanism towards treatment and prediction

Foley, É. M., & Khandaker, G. M. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00056-1 · Cited by 7

Schizophrenia, Human Leukocyte Antigen (HLA), and Herpes Viruses: Immunogenetic Associations at the Population Level

James, L. M., Charonis, S. A., & Georgopoulos, A. P. (2023) · Neuroscience Insights · doi:10.1177/26331055231166411 · Cited by 7

Lipid‐correlated alterations in the transcriptome are enriched in several specific pathways in the postmortem prefrontal cortex of Japanese patients with schizophrenia

Arihisa, W., Kondo, T., Yamaguchi, K., Matsumoto, J., Nakanishi, H., Kunii, Y., Akatsu, H., Hino, M., Hashizume, Y., Sato, S., et al. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12368 · Cited by 6

Association between Psychotic Disorders and Psoriasis or Psoriatic Arthritis: Cohort Study of French Health Insurance Database

Brenaut, E., Godin, O., Leboyer, M., Tamouza, R., Assan, F., Pignon, B., & Sbidian, É. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.01.005 · Cited by 7

Hematological and inflammatory markers in Han Chinese patients with drug-free schizophrenia: relationship with symptom severity

Yang, C., Tian, Y., Yang, X., Liu, L., Chen, L., Xia, L., & Liu, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1337103 · Cited by 7

Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?

González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., de la Fuente-Tomás, L., García, C. I., Sáiz, P. A., Rodríguez‐González, S., Coto‐Montes, A. M., & Bobes, J. (2019) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2018.03.003 · Cited by 7

Neuronal surface autoantibodies, encephalitis, and psychosis: from neurology to psychiatry

Pollak, T. A., Al‐Diwani, A., & Lennox, B. (2017) · Advances in Clinical Neuroscience & Rehabilitation · doi:10.47795/llep2170 · Cited by 7

The Role of the Second Extracellular Loop of Norepinephrine Transporter, Neurotrophin-3 and Tropomyosin Receptor Kinase C in T Cells: A Peripheral Biomarker in the Etiology of Schizophrenia

Rodrígues-Amorím, D., Iglesias‐Martínez‐Almeida, M., Baltanás, T. R., Fernández-Palleiro, P., Freiría‐Martínez, L., Rodríguez-Jamardo, C., Comís‐Tuche, M., Vallejo-Curto, M. D. C., Álvarez-Ariza, M., López-García, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168499 · Cited by 7

Unravelling the Neuroinflammatory Mechanisms Underlying the Effects of Social Defeat Stress on Use of Drugs of Abuse

Montagud‐Romero, S., Miñarro, J., & Rodríguez‐Arias, M. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_260 · Cited by 7

Editorial: Activation and de-activation of inflammatory pathways. The disequilibrium of immune-neuro-endocrine networks in psychiatric disorders

Drexhage, H. A. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.01.007 · Cited by 7

Phage-Microbiota Crosstalk: Implications for Central Nervous System Disorders

Salari, V., Parrella, E., Mengoni, F., Cintra, L., Bertini, G., & Fabene, P. F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136183 · Cited by 6

Clinical Relevance of Peripheral Interleukins in Drug-Naive First-Episode Psychosis: Symptom-Specific Associations from the PANSS Dimensions

Binić, I., Petrovic, J., Žikić, O., Tošić-Golubović, S., Djordjevic, V., Stevanovic, M., Krtinić, D., & Apostolovic, M. A. (2025) · Brain Sciences · doi:10.3390/brainsci15090932 · Cited by 6

Association between cognitive function and IL-18 levels in schizophrenia: Dependent on IL18 − 607 A/C polymorphism

Guan, X., Leng, W., Hu, Q., Xiu, M., & Zhang, X. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106386 · Cited by 6

Neurobiological Perturbations in Bipolar Disorder Compared With Schizophrenia: Evidence From Cell Cultures and Brain Organoids

Akkouh, I. A., Osete, J. R., Szabó, A., Andreassen, O. A., & Djurovic, S. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.02.012 · Cited by 9

Deconstruct the link between gut microbiota and neurological diseases: application of Mendelian randomization analysis

Li, J., Hu, X., Tao, X., Li, Y., Jiang, W., Zhao, M., Ma, Z., Chen, B., Sheng, S., Tong, J., et al. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1433131 · Cited by 6

A Case of Psychosis in a Patient with Secondary Adrenal Insufficiency: A Possible Etiological Role of a Hypocortisolemic-induced Increase in Proinflammatory Cytokines.

Spiegel, D. R., Nelson, A. B., Lieb, D. C., Pattison, A., Smith, J. M., Zigrossi, P., & Godbout, E. (2017) · PubMed Central · Cited by 6

Cerebral Structural Abnormalities and Their Associations With Peripheral Cytokine Levels in a Group of Untreated Patients With Nasopharyngeal Carcinoma

Wang, Y., Zhang, W., Wu, X., Luo, X., Li, S., Zhu, G., Liu, J., Gong, Q., Jiang, Y., & Lui, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.740033 · Cited by 6

Molecular-genetic and immunological aspects of the formation of psychopathological symptoms in schizophrenia

Голимбет, В. Е., & Klyushnik, T. P. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212210166 · Cited by 6

Cognitive function in recovered COVID-19 Lebanese patients with schizophrenia

Haddad, C., Chamoun, A., Sacre, H., Hallit, S. R., Salameh, P., & Calvet, B. (2023) · Annals of General Psychiatry · doi:10.1186/s12991-023-00435-4 · Cited by 7

Between Mind and Body? Psychoneuroimmunology, Psychology, and Cognitive Science

Gough, J. (2023) · Perspectives on Science · doi:10.1162/posc_a_00626 · Cited by 6

Internalising symptoms mediate the longitudinal association between childhood inflammation and psychotic-like experiences in adulthood

Francesconi, M., Minichino, A., Khandaker, G. M., Midouhas, E., Lewis, G., & Flouri, E. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.07.035 · Cited by 6

Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells

van Hugte, E., & Kasri, N. N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9721-0_15 · Cited by 6

Relationship of Neuropeptide S with Clinical and Metabolic Parameters of Patients during Rehabilitation Therapy for Schizophrenia

Markiewicz-Gospodarek, A., Markiewicz, R., Dobrowolska, B. B., Maciejewski, R., & Łoza, B. (2022) · Brain Sciences · doi:10.3390/brainsci12060768 · Cited by 6

Salivary Inflammatory Markers in Trichotillomania: A pilot study

Grant, J., & Chamberlain, S. (2018) · Neuropsychobiology · doi:10.1159/000489865 · Cited by 8

Expression of Toll-like receptors 4 and 7 in murine peripheral nervous system development

Arnaboldi, F., Sommariva, M., Opizzi, E., Rasile, M., Camelliti, S., Busnelli, M., Menegola, E., Renzo, F. D., Menon, A., & Barajon, I. (2020) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2020.151526 · Cited by 7

G Protein-Coupled Estrogen Receptor 1 (GPER) as a Novel Target for Schizophrenia Drug Treatment

Macêdo, D. S., Sanders, L. L. O., das Candeias, R., Montenegro, C. D. F., de Lucena, D. F., Filho, A. J. M. C., Seeman, M. V., & Monte, A. S. (2020) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgaa062 · Cited by 8

Urolithin A alleviates schizophrenic-like behaviors and cognitive impairment in rats through modulation of neuroinflammation, neurogenesis, and synaptic plasticity

Huang, Z., Ren, Z., Wang, S., Xiao, L., Ling, Y., Xie, Y., Wang, G., & Zhou, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-93554-9 · Cited by 5

Monocytic TLR4 expression and activation in schizophrenia: A systematic review and meta-analysis

Jameie, M., Bordbar, S., Samiee, R., Amanollahi, M., Looha, M. A., Aleyasin, M. S., Homayuni, M. R. A., Mozafar, M., Jameie, S. B., & Akhondzadeh, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319171 · Cited by 6

Distinct Gut Microbial Signatures and Diminished Anti-Inflammatory Effect of Short-Chain Fatty Acids in Schizophrenia With Immune Activation

He, X., Gao, Y., Zhang, Y., Yang, Z., Wang, C., Ma, Q., Lei, P., Lu, Y., Fan, Y., Liu, R., et al. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf110 · Cited by 5

Common Issues Among Asthma, Epilepsy, and Schizophrenia: From Inflammation to Ca2+/cAMP Signalling

Bergantin, L. B. (2020) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523019999201110192029 · Cited by 5

Skewing of the antibody repertoire in cerebrospinal fluid B cells from healthy controls and patients with schizophrenia

Husain-Krautter, S., Lee, J., Vos, D., Gallego, J. A., Malhotra, A. K., & Rothstein, T. L. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113743 · Cited by 5

Rethinking Immunity and Cognition in Clinical High Risk for Psychosis

Griffiths, S. L., Upthegrove, R., Zuelli, F. M. D. G. C., & Deakin, J. F. W. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_399 · Cited by 5

Psychiatric polygenic risk as a predictor of COVID-19 risk and severity: insight into the genetic overlap between schizophrenia and COVID-19

Alemany-Navarro, M., Almeida, S. D., Cruz, R., Riancho, J. A., Rojas‐Martínez, A., Lapunzina, P. D., Flores, C., Scourge Cohort Group, & Carracedo, A. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02482-7 · Cited by 5

Fecal Microbiota Underlying the Coexistence of Schizophrenia and Multiple Sclerosis in Chinese Patients

Shao, L., Fu, J., Xie, L., Cai, G., Cheng, Y., Zheng, N., Zeng, P., Yan, X., Ling, Z., & Ye, S. (2023) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2023/5602401 · Cited by 5

Psychiatric co‐morbidity in patients with hidradenitis suppurativa: A cross‐sectional study of clinical characteristics and burden of disease

Holgersen, N. K., Nielsen, V. W., Ring, H. C., Rosenø, N. A. L., Egeberg, A., Thyssen, J. P., & Thomsen, S. F. (2023) · JEADV Clinical Practice · doi:10.1002/jvc2.222 · Cited by 5

Anti-SFT2D2 autoantibodies alter dendrite spine and cause psychotic behavior in mice

Liu, D., Jin, Z., Wei, H., Zhu, C., Liu, K., You, P., Ju, J., Xu, J., Zhu, W., & Xu, Q. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.01.015 · Cited by 5

The role of the immune system in early-onset schizophrenia: identifying immune characteristic genes and cells from peripheral blood

Chen, Z., Li, Y., Gao, Y., Fan, X., Du, X., Li, X., Liu, Z., Liu, S., & Cao, X. (2024) · BMC Immunology · doi:10.1186/s12865-024-00618-y · Cited by 5

Bridging cholinergic signalling and inflammation in schizophrenia

Metz, C. N., Brines, M. L., & Pavlov, V. A. (2024) · Schizophrenia · doi:10.1038/s41537-024-00472-2 · Cited by 5

Unraveling multi‐scale neuroimaging biomarkers and molecular foundations for schizophrenia: A combined multivariate pattern analysis and transcriptome‐neuroimaging association study

Peng, Y., Chai, C., Xue, K., Tang, J., Wang, S., Su, Q., Liao, C., Zhao, G., Wang, S., Zhang, N., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14906 · Cited by 4

Psychoneuroimmunology in the Daily Clinic is Only Possible Within a Contextual Frame

Pruimboom, L., Rocio, F. A., & Ledesma, S. N. (2024) · Integrated science · doi:10.1007/978-3-031-73061-0_16 · Cited by 5

Comprehensive transcriptome analysis and lncRNA-miRNA-mRNA establishment of schizophrenia based on induced pluripotent stem cells

Jia, N., Yin, X., Zhu, Z., Hou, W., Yang, Q., Zhu, H., Zhang, H., Yu, X., Yu, Q., & Hui, L. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.04.027 · Cited by 5

The role of inflammation in the relationship of self-rated health with mortality and implications for public health: Data from the English Longitudinal Study of Aging (ELSA)

Gupta, S., Xu, Y., & Montgomery, S. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100139 · Cited by 5

Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort

Fond, G. B., de Verville, P. L. S., Richieri, R. M., Etchecopar‐Etchart, D., Korchia, T., Faugère, M., Godin, O., Schürhoff, F., Berna, F. S., Aouizerate, B., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110335 · Cited by 6

Sex-Specific Cannabidiol- and Iloperidone-Induced Neuronal Activity Changes in an In Vitro MAM Model System of Schizophrenia

Thériault, R.-K., St‐Denis, M., Hewitt, T., Khokhar, J. Y., Lalonde, J., & Perreault, M. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115511 · Cited by 5

Prospective, observational, single-centre cohort study with an independent control group matched for age and sex aimed at investigating the significance of cholinergic activity in patients with schizophrenia: study protocol of the CLASH-study

Schick, B., Barth, E., Mayer, B., Weber, C.-L., Hagemeyer, T., & Schönfeldt‐Lecuona, C. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050501 · Cited by 5

Central insulin dysregulation in antipsychotic-naïve first-episode psychosis: In silico exploration of gene expression signatures

Lee, J., Xue, X., Au, E., McIntyre, W. B., Asgariroozbehani, R., Tseng, G. C., Papoulias, M., Panganiban, K. J., Agarwal, S. M., McCullumsmith, R. E., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115636 · Cited by 5

Toxoplasma gondii and Schizophrenia: A Relationship That Is Not Ruled Out

Sorlózano, A., & Fernández, J. G. (2016) · InTech eBooks · doi:10.5772/66018 · Cited by 4

Association Between Clinical Symptoms and Inflammatory Markers in First-Episode Unmedicated Patients with Major Depressive Disorder

Guan, H., Sun, J., Cheng, J., Chen, L., Zhao, Y., Yang, X., Wang, D., & Zhang, X. (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s582480 · Cited by 4

Disruptions in serotonin- and kynurenine pathway metabolism in post-COVID: biomarkers and treatment

Rus, C. P. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1532383 · Cited by 5

Examining the Moderating Effect of Sex on the Association Between Asthma and Age of Onset in Bipolar Disorder and Schizophrenia

Michel, I. M., Gardea‐Resendez, M., Ercis, M., Ortiz‐Orendain, J., Ali, D. N., Pazdernik, V., Miola, A., González-Campos, T., Bostan, S., Bisoglio, J., et al. (2025) · Journal of the Academy of Consultation-Liaison Psychiatry · doi:10.1016/j.jaclp.2025.06.002 · Cited by 4

Synthetic microneurotrophins: Neurotrophin receptors for therapeutics of neurodegenerative diseases

Zota, I., Calogeropoulou, T., Chanoumidou, K., Charalampopoulos, I., & Gravanis, A. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70143 · Cited by 5

Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia

Sapienza, J., Spangaro, M., Comai, S., Sabé, M., Torre, J. T. L., Buonarroti, M., Cavallaro, R., & Bosia, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188949 · Cited by 5

The effect of stress on the immune system in the course of tumor from the biomedical perspective

Rolińska, A., Furmaga, J., & Czyżewski, W. (2017) · Psychoonkologia · doi:10.5114/pson.2017.71381 · Cited by 4

The Effect of Valproic Acid on the Transcriptional Activity of Ngf and Bdnf Genes of in Vitro Cultured Neurons Under Oxidative Stress Conditions

Filev, A. D., Ershova, E. S., Savinova, E. A., Кalakov, A. M., Вейко, Н. Н., Umriukhin, P. E., & Kostyuk, S. V. (2021) · International Journal of Biology and Biomedical Engineering · doi:10.46300/91011.2021.15.45 · Cited by 4

The Strategy of Targeting Peroxisome Proliferator-Activated Receptor (PPAR) in the Treatment of Neuropsychiatric Disorders

Matrisciano, F., & Pinna, G. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_22 · Cited by 5

Eosinophils and Cognitive Impairment in Schizophrenia: A New Perspective

Obeagu, E. I., & Bluth, M. H. (2024) · Journal of Blood Medicine · doi:10.2147/jbm.s451988 · Cited by 4

Remission in schizophrenia spectrum disorders: A randomized trial of amisulpride, aripiprazole and olanzapine

Drosos, P., Johnsen, E., Bartz-Johannessen, C. A., Larsen, T. K., Reitan, S. K., Rettenbacher, M. A., & Kroken, R. A. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.06.047 · Cited by 4

Implications of immunity and inflammation in schizophrenia and related psychotic disorders

Perestrelo, J., Mota, D. C. M., Coutinho, A., Santos, M. A. B. D., & Lapa, G. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2016.01.2163

Imunne system and schyzophrenia

Almeida, A., Teixeira, T. M., & Quarenta, J. (2022) · European Psychiatry · doi:10.1192/j.eurpsy.2022.1806

Imunologia da esquizofrenia: evidências, perspectivas e desafios

de Campos-Carli, S. M., Salgado, J. V., & Teixeira, A. L. (2016) · Debates em Psiquiatria · doi:10.25118/2763-9037.2016.v6.136

Is there a role for immune-to-brain communication in schizophrenia?

Khandaker, G. M., & Dantzer, R. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3975-1 · Cited by 170

The Role of Inflammation in the Etiology and Treatment of Schizophrenia

Köhler-Forsberg, O., & Lennox, B. (2020) · Frontiers research topics · doi:10.3389/978-2-88966-269-2 · Cited by 2